Javascript must be enabled to continue!
The use of aprepitant in a case of refractory nausea and vomiting
View through CrossRef
Background:
This case report describes a patient whose refractory nausea and vomiting significantly improved with the use of aprepitant, a neurokinin receptor antagonist currently only licensed for short-term use in chemotherapy-induced nausea and vomiting.
Case presentation:
A patient with breast cancer and meningeal metastases had an 18-month history of nausea and vomiting refractory to a number of antiemetics commonly used in palliative care. The nausea and vomiting resolved after receiving two doses of the drug aprepitant.
Case management and outcome:
Maintenance antiemetic treatment with aprepitant was continued over a 5-month period with no recurrence of nausea and vomiting, and no observed side effects.
Conclusions:
Aprepitant has a potential role as an antiemetic for refractory symptoms within the palliative-care setting.
Title: The use of aprepitant in a case of refractory nausea and vomiting
Description:
Background:
This case report describes a patient whose refractory nausea and vomiting significantly improved with the use of aprepitant, a neurokinin receptor antagonist currently only licensed for short-term use in chemotherapy-induced nausea and vomiting.
Case presentation:
A patient with breast cancer and meningeal metastases had an 18-month history of nausea and vomiting refractory to a number of antiemetics commonly used in palliative care.
The nausea and vomiting resolved after receiving two doses of the drug aprepitant.
Case management and outcome:
Maintenance antiemetic treatment with aprepitant was continued over a 5-month period with no recurrence of nausea and vomiting, and no observed side effects.
Conclusions:
Aprepitant has a potential role as an antiemetic for refractory symptoms within the palliative-care setting.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to b...
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation in Microglia and Suppresses Inflammatory Pain
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation in Microglia and Suppresses Inflammatory Pain
Abstract
Background: Substance P (SP) contributes to the pathogenesis of pain by acting on neurokinin‐1 receptor (NK-1R), specialized sensory neurons that detect noxious st...
Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults
Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults
Purpose
Use of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in patients unable to swallow capsules is hindered by the lack of a commercia...
Incidence and risk factors of postoperative nausea and vomiting in Africa among patient under gone surgery: a systematic review and meta-analysis
Incidence and risk factors of postoperative nausea and vomiting in Africa among patient under gone surgery: a systematic review and meta-analysis
Background:
Patients who experience postoperative nausea and vomiting are not happy with their surgical outcomes. Preventing this problem expedites the patients’ return...
Aprepitant for the Treatment of Chronic Refractory Pruritus
Aprepitant for the Treatment of Chronic Refractory Pruritus
Chronic pruritus is a difficult condition to treat and is associated with several comorbidities, including insomnia, depression, and decreased quality of life. Treatment for chroni...
KURANGI EMESIS GRAVIDARUM DENGAN AROMA JERUK NIPIS
KURANGI EMESIS GRAVIDARUM DENGAN AROMA JERUK NIPIS
Emesis gravidarum is vomiting in pregnant women (Medical Dictionary). This situation is usually preceded by nausea (Nausea). In the United States and Canada between 400,000 and 350...
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
16510 Background: Preparative regimens for BMT are associated with a high incidence of nausea and vomiting, which can negatively affect quality of life. It is important to evaluat...

